Cargando…
Whether Erythropoietin can be a Neuroprotective Agent against Premature Brain Injury: Cellular Mechanisms and Clinical Efficacy
Preterm infants are at high risk of brain injury. With more understanding of the preterm brain injury's pathogenesis, neuroscientists are looking for more effective methods to prevent and treat it, among which erythropoietin (Epo) is considered as a prime candidate. This review tries to clarify...
Autores principales: | Ma, Xueling, Shi, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608225/ https://www.ncbi.nlm.nih.gov/pubmed/34030616 http://dx.doi.org/10.2174/1570159X19666210524154519 |
Ejemplares similares
-
Erythropoietin: a multimodal neuroprotective agent
por: Byts, Nadiya, et al.
Publicado: (2009) -
Application of brain ultrasound in premature infants with brain injury
por: Liu, Lu
Publicado: (2023) -
Neuroprotective effects of erythropoietin against oxidant injury following brain irradiation: an experimental study
por: Ugurluer, Gamze, et al.
Publicado: (2016) -
Neuroprotection in Traumatic Brain Injury: Mesenchymal Stromal Cells can Potentially Overcome Some Limitations of Previous Clinical Trials
por: Carbonara, Marco, et al.
Publicado: (2018) -
The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage
por: Yoo, Seung-Jun, et al.
Publicado: (2017)